Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who ...

Viking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its ...

Ignore the noise in GLP-1 stocks. Find the best value instead.

Novo Nordisk and Eli Lilly currently control 99% of the market, but their dominance may weaken as new entrants introduce ...

Novo Nordisk said Wednesday it will sell Wegovy for $499 a month in cash to patients who can’t get the blockbuster weight-loss drug through insurance, a bid to reach consumers who can’t afford the $1, ...

All told, Eli Lilly has tallied up about $23 billion in ... Lilly also has a $2.5 billion plant under construction in Alzey, Germany, which is expected to begin production in 2027.

Eli Lilly CEO David Ricks speaks during a press conference on the day of a groundbreaking ceremony to mark the beginning of construction of a new plant in Alzey, Germany, on April 8, 2024.

Feb 20 (Reuters) - Eli Lilly (LLY.N), opens new tab is betting ... spreads 7:44 AM UTC Healthcare & Pharmaceuticalscategory Germany regains status as free of foot-and-mouth disease, ministry ...

President Trump threatened to impose a 200% tariff on EU wines and champagne unless the EU rescinds its 50% tax on US alcohol ...

Novo Nordisk and Eli Lilly currently control 99% of the market ... Wegovy is available in the US, Denmark, Norway, Germany, and the UK, with launches in Japan and other European markets expected ...